Psyched Wellness | Psyched Wellness Is Excited To Announce That Calm Has Been Listed on the World’s Largest eCommerce Marketplace,

Press Release

Psyched Wellness Is Excited To Announce That Calm Has Been Listed on the World’s Largest eCommerce Marketplace,

Toronto, Ontario--(Newsfile Corp. – March 23rd 2023) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is excited to announce that Calm has been approved and listed on Amazon is the leading global e-commerce marketplace and the world’s second largest retailer, overall. Amazon’s retail business reported revenue of approximately $280 billion, providing a massive audience and consumer landscape for Calm to flourish. Calm’s listing on can be viewed at The product will be available to all customers residing in the United States.

Matthew Singh, Psyched Wellness Chief Commercial Officer, commented, “Any robust eCommerce strategy must include a partner as influential and accessible as Amazon. Our sales and distribution partner TruLife did an incredible job activating this listing quickly and efficiently. We will now optimize the listing itself and set to work ensuring the item discoverability constantly improves within the Amazon ecosystem. Calm is now available in a marketplace that nearly all of our target demographic currently shop. Listing our product on Amazon will go a long way to building trust in the market and ensures constant availability for all those interested in trying Calm. Additional thanks to the Amazon team for their ongoing collaboration in making this happen. Psyched Wellness and TruLife will continue to focus on expanding to additional 3rd party eComm and brick and mortar retailers, in the coming months.”

Mr Singh has a multitude of experience running eComm teams and departments at companies like Red Bull Canada and consulting via various CPG startups. Beyond their eCommerce initiatives, Psyched Wellness would like to remind retail buyers that TruLife distribution will be representing their brand at the upcoming ECRM conference taking place March 21 – 23rd.

Psyched Wellness will be growing their route-to-market partnerships, throughout the nation. If you are interested in distributing/listing Calm please reach out to

Visit for more information about ordering the product directly.



Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.

About Psyched Wellness Ltd.:

Psyched Wellness Ltd. is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods. The Company’s objective is to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category. The Company is in the process of developing a line of Amanita muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives: promote stress relief, relaxation and assist with restful sleeping.

Cautionary Statement Regarding Forward Looking Information

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. The forward-looking information and forward- looking statements contained herein include, but are not limited to, statements regarding: the ability of the Company to develop Amanita Muscaria-derived products; the safety of Amanita Muscaria consumption and the safety and purity of any extracts thereof; and (ii) the uses and potential benefits of Amanita Muscaria.

Forward-looking information in this news release are based on certain assumptions and expected future events, namely: the Company’s ability to continue as a going concern; the Company’s ability to continue to develop its mushroom-derived products and associated consumer packaged goods; continued approval of the Company’s activities by the relevant governmental and/or regulatory authorities; and the continued growth of the Company.

These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the potential inability of the Company to continue as a going concern; risks associated with potential governmental and/or regulatory action with respect to the Company’s operations; competition within the psychedelics market; risks with respect to the safety of Amanita Muscaria consumption and the safety and purity of any extracts thereof; and the risk that there is no potential benefit of Amanita Muscaria consumption.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

For further information, please contact:

Jeffrey Stevens
Chief Executive Officer
Psyched Wellness Ltd.
t: (647) 400-8494

Investor Contacts:
Tim Regan/Sophia Bashford
KCSA Strategic Communications
t: (978) 505-2478